Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Novavax (NVAX) witnessed a jump in share price last session on above-average trading ...

Shares of this vaccine maker have returned -13.6% over the past month versus the Zacks S&P 500 composite's +1% change. The Zacks Medical - Biomedical and Genetics industry, to which Novavax ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through ...